NaviGate Cardiac Structures, Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient


Aug 30, 2017   •  Business Wire

LAKE FOREST, Calif., Aug. 30, 2017 - NaviGate Cardiac Structures Inc. ("NCSI") announced today that its GATE™ catheter-guided tricuspid atrioventricular valved stent (A VS) was implanted through the jugular vein six weeks ago into a patient's transplanted heart that was failing due to severe tricuspid valve insufficiency. The successful implantation of the GATE™ A VS at the Policlinico of the…

View Press Release

FOR IMMEDIATE RELEASE - Contact: Ronald Trahan, APR, Ronald Trahan Associates, 1 (508) 359-4005, x108